Pharmaceuticals

Industry Forecast: Plasma Fractionation Market to Generate $50.54 Billion Revenue by 2029

August 21, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#How Will the Plasma Fractionation Market Evolve in Terms of Growth and Size by 2029?#_x000D_

The substantial increase in the size of the plasma fractionation market has been evident in recent years. There is anticipated growth evident, from $31.42 billion in 2024 to $34.14 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. This growth during the former period can be ascribed to several factors, including an increased occurrence of hemophilia and immune deficiency disorders, a larger aging demographic, growing demand for immunoglobulins, expanding plasma collection centers, and an increase in surgical procedures._x000D_

_x000D_

Anticipations of robust growth are projected for the plasma fractionation market size in the forthcoming years, with estimates putting it at a worth of $50.54 billion in 2029 while registering a compound annual growth rate (CAGR) of 10.3%. Various factors like the increase in global healthcare spending, the expanding use of plasma-derived pharmaceutical products, the surge in investment in research & development, the rising use of plasma in neurology treatments, and the broadening of plasma fractionation facilities contribute to this predicted growth. The forecast period also anticipates significant trends such as the innovation of new fractionation techniques, a shift towards albumin and immunoglobulin therapies, heightened demand for specialized plasma products, an emphasis on pathogen inactivation technologies, along with strategic alliances and partnerships within the plasma industry._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp_x000D_

_x000D_

#What factors are expected to fuel Plasma Fractionation market growth in the coming years?#_x000D_

The anticipated growth of the plasma fractionation market is primarily fueled by the escalating prevalence of chronic diseases. These diseases, which require continuous medical intervention and last over a year, envelop conditions such as heart disease, cancer, and diabetes. By receiving access to plasma products, patients with these enduring illnesses can minimize their morbidity rate, enhance their quality of life and reduce treatment costs, naturally boosting the market demand for plasma fractionation. For example, a January 2023 report from the National Library of Medicine, an American institution, anticipates a 99.5% increase in the number of individuals aged 50 and over with one or more chronic diseases. This figure is projected to reach 142.66 million by 2050, contrasting with the 71.522 million recorded in 2020 within the United States. This surge in chronic disease cases is a significant driving force behind the expansion of the healthcare analytical testing service market. Thus, the growing number of chronic diseases across all age groups is projected to spur on the growth of the plasma fractionation market._x000D_

_x000D_

#What Are The Key Findings From The Segmentation Analysis Of The Plasma Fractionation Market?#_x000D_

The plasma fractionation market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors _x000D_

2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology_x000D_

3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes_x000D_

_x000D_

Subsegments:_x000D_

1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG) _x000D_

2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC) _x000D_

3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA) _x000D_

4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH) _x000D_

_x000D_

#Which Trends Are Expected To Shape The Future Of The Plasma Fractionation Market?#_x000D_

Leading companies in the market are embracing innovative technologies such as advanced facility processes which convert donated human plasma into essential medicines, enhancing both efficiency and safety. In March 2023, for example, German-based company CSL Behring launched a new plasma fractionation facility valued at $470 million, utilizing state-of-the-art technology to enhance the effectiveness and safety of plasma processing in order to guarantee higher-quality and more dependable medications. This facility aids in accommodating the increasing demand by supplementing the supply of these vital medicines, thereby expanding the number of patients who can benefit from life-saving therapies. The application of advanced automation and self-cleaning systems diminishes the chance of contamination, improves overall sanitary conditions, and boosts patient safety._x000D_

_x000D_

#What Are The Most Active Companies In The Plasma Fractionation Market Today?#_x000D_

Major companies operating in the plasma fractionation market include Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP _x000D_

_x000D_

#Get The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report_x000D_

_x000D_

#Which Regional Markets Are Attracting The Most Investment In Plasma Fractionation?#_x000D_

North America was the largest region in the plasma fractionation market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7543&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_